Buckingham Capital Management, Inc. Eli Lilly & CO Transaction History

Buckingham Capital Management, Inc.

$815 Million
Q1 2024

A detailed history of Buckingham Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 10,740 shares of LLY stock, worth $10.1 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

10,740

Previous 11,281 4.8%

Holding current value

$10.1 Million

Previous $6.58 Million 27.07%

% of portfolio

1.03%

Previous 0.88%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$592.2 - $792.28 $320,380 - $428,623	-541 Reduced 4.8%	10,740 $8.36 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $514,161 - $606,128	-979 Reduced 7.99%	11,281 $6.58 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $882,441 - $1.22 Million	-2,030 Reduced 14.21%	12,260 $6.59 Million
Q2 2023 Jul 11, 2023	SELL	$350.74 - $468.98 $576,967 - $771,472	-1,645 Reduced 10.32%	14,290 $6.7 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $310,319 - $364,455	-999 Reduced 5.9%	15,935 $5.47 Million

Q4 2022 Jan 24, 2023	SELL	$321.55 - $374.67 $258,526 - $301,234	-804 Reduced 4.53%	16,934 $0
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $474,071 - $540,254	-1,599 Reduced 8.27%	17,738 $5.74 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $587,841 - $690,212	-2,109 Reduced 9.83%	19,337 $6.27 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $307,913 - $382,657	-1,312 Reduced 5.77%	21,446 $6.14 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $314,340 - $390,097	-1,398 Reduced 5.79%	22,758 $6.29 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $410,403 - $505,058	-1,852 Reduced 7.12%	24,156 $5.58 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $36,110 - $46,708	-200 Reduced 0.76%	26,008 $5.97 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $67,535 - $87,427	411 Added 1.59%	26,208 $4.9 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $153,420 - $203,012	1,176 Added 4.78%	25,797 $4.36 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $201,783 - $233,399	1,380 Added 5.94%	24,621 $3.64 Million
Q2 2020 Jul 20, 2020	BUY	$136.42 - $164.18 $582,240 - $700,720	4,268 Added 22.5%	23,241 $3.82 Million
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $54,048 - $66,896	454 Added 2.45%	18,973 $2.63 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $845,309 - $1.05 Million	7,906 Added 74.49%	18,519 $2.43 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $736,851 - $801,504	6,900 Added 185.83%	10,613 $1.19 Million
Q1 2019 May 07, 2019	BUY	$111.31 - $131.02 $188,781 - $222,209	1,696 Added 84.09%	3,713 $482,000
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $213,600 - $239,296	2,017 New	2,017 $233,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $893B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.

Account

Buckingham Capital Management, Inc. Eli Lilly & CO Transaction History